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THE DESCENDING BRANCH OF THE LATERAL FEMORAL CIRCUMFLEX ARTERY FOR CORONARY
ARTERY BYPASS GRAFTING
Yuzuru Sakakibara, MD, Masakazu Abe, MD, Yuji Hiramatsu, MD, Osamu Shigeta, MD, Shigemi Ishikawa, MD,
Tomoaki Jikuya, MD, and Toshio Mitsui, MD, Tsukuba, Japan
Tatsumi and associates1 attempted to use the lateral
femoral circumflex artery (LFCxA) as a free graft for coro-
nary bypass (CABG) surgery. However, the LFCxA may play
an important role as a collateral root in patients with femoro-
popliteal occlusive disease (arteriosclerosis obliterans).2 Both
the applicability of the LFCxA as a bypass conduit and the
suitability of sacrificing it at the risk of limb ischemia have to
be evaluated. We carried out an angiographic study to deter-
mine the suitability of the LFCxA as a free arterial graft for
myocardial revascularization.
Patients and methods. Vascular records and panangio-
graphic evaluations of the lower extremities from 1977 to
1989 were reviewed to identify all patients whose diagnosis
of arteriosclerosis obliterans had been based on clinical char-
acteristics and confirmed by angiography. Seventy-nine
patients (120 limbs) were identified as having arteriosclerosis
obliterans, meeting the conditions for precise measurement
of LFCxAs in this study. Patients who had previous femoral
artery surgery were excluded from this study. Seventy-one
men and 8 women ranging from 40 to 83 years of age (mean
66.4 years) were examined. The maximal luminal diameter of
the LFCxA was measured with a Digimatic caliper (Mitutoyo
Corporation, Kawasaki, Kanagawa, Japan). The length of the
LFCxA was measured between the origin of a descending
branch of the LFCxA and the point of inner luminal diameter
of 1.5 mm (L > 1.5 mm) (Fig 1). Data were expressed as
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mean ± standard deviation. The Student t test was used for
statistical analysis.
Results. On the basis of the arteriographic findings, these
patients were divided into the following 2 groups: the collat-
eral (+) group, in which a main collateral channel of the
femoro-popliteal segment may play a significant role in dis-
tal circulation (n = 48 limbs: 40%), and the collateral (–)
group, in which the LFCxA does not act as a major collater-
al vessel (n = 72 limbs: 60%). The maximum inner diameter
of the descending branch of the LFCxA was 2.06 ± 0.55 mm
in the collateral (–) group and 2.95 ± 0.66 mm in the collat-
eral (+) group (P < .001). L > 1.5 mm was 6.0 ± 4.3 cm in the
collateral (–) group and 16.7 ± 5.4 cm in the collateral (+)
group (P < .001) (Table I).
Atherosclerotic changes of the LFCxA, which are indicated
as wall irregularities, were recognized in 43 limbs (35.8% of
all those investigated). Useful LFCxAs for CABG free grafts
(not a major collateral channel, without atherosclerotic change,
more than 10 cm in pedicle length, and more than 1.5 mm in
inner diameter) were recognized in only 12 limbs (10.0%). 
Discussion. Although many types of arterial graft materials
are currently being used, surgeons are still searching for new
grafts.3 Tatsumi and associates1 used the descending branch of
the LFCxA as a free graft for CABG while making note of the
large caliber and length of the LFCxA. Vaas,4 however, inves-
tigated the extent of atherosclerotic lesions of the LFCxA 1
cm beyond its origin using 100 cadavers of over 45 years of
age. The percentage of narrowing at the investigated sites
(LFCxA) was 23% ± 22% in 56 men and 10% ± 15% in 44
women. In his study, the percentages of atherosclerosis were
not statistically different from those of the superficial femoral
artery and those of the proximal portion of the deep femoral
artery. Haimovici2 reported that the overall incidence of ather-
osclerotic changes in the profunda femoris was 9.5% in a non-
diabetic group of patients and 30.5% in a diabetic group. In
the present study, wall irregularities of the LFCxA were noted
in 35.8% of all investigated limbs. Our study confirms the
finding of a high incidence of atherosclerotic changes of the
LFCxA in patients with arteriosclerosis obliterans. 
Moreover, the profunda femoris and the descending branch
of the LFCxA play an important role as a main collateral
channel in patients with femoro-popliteal obstructive disease.
In the present study, 40% of the total LFCxAs had become
major collateral roots for peripheral circulation. Significantly
larger calibers of LFCxAs were noted in the collateral (+)
group than in the collateral (–) group. The LFCxAs with large
diameters were potentially important collateral channels that
could not be harvested. Our results suggest that lower extrem-
ity angiography should be performed in all patients in whom
the use of the LFCxA as a graft is being considered.
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Fig 1. The descending branch of the lateral femoral circum-
flex artery (LFCxA). Max-D, Maximal inner diameter of the
LFCxA (mm); SFA, superficial femoral artery. Straight line
measurement of the length of the LFCxA pedicle from (A)
the origin of the descending branch of the LFCxA to (B) the
point of inner luminal diameter of 1.5 mm (L > 1.5 mm).
Table I. Measurement data for LFCxA
Numbers or data Percent
Collateral (–) group 72 limbs 60
Max-D 2.1 ± 0.6 mm
L > 1.5 mm 6.0 ± 4.3 cm
Atherosclerotic change 22 limbs 30.6
Collateral (+) group 48 limbs 40
Max-D 3.0 ± 0.7 mm*
L > 1.5 mm 16.7 ± 5.4 cm*
Atherosclerotic change 21 limbs 43.8 (NS)
LFCxA, Lateral femoral circumflex artery; Max-D, maximum diameter of the
descending branch of the LFCxA; L > 1.5 mm, the length of the LFCxA pedi-
cle with an inner diameter of more than 1.5 mm; NS, not significant. Data are
shown as the mean ± the standard deviation.
*P < .001.
